USAID facilitates access to six tuberculosis medicines in Uzbekistan
- Written by TCA
TASHKENT — The U.S. Agency for International Development (USAID), in partnership with the Agency for Development of Pharmaceutical Industry of Uzbekistan, has facilitated the expedited registration of six tuberculosis (TB) medications over the last year and a half. With USAID technical assistance, Uzbekistan’s Ministry of Health adopted the World Health Organization (WHO)’s collaborative registration procedure for the accelerated registration of medicines (CRP) which facilitates rapid, safe access to new medicines for TB patients in Uzbekistan, the U.S. Embassy in Uzbekistan said on October 5.
